NCT03414008View on ClinicalTrials.gov

This Study Tests How Different Doses of BI 1291583 Are Taken up in the Body and How Well They Are Tolerated

PHASE1TerminatedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

February 5, 2018

Primary Completion Date

November 18, 2019

Study Completion Date

November 18, 2019

Conditions
Healthy
Interventions
DRUG

BI 1291583

Single dose

DRUG

Matching placebo: Tartaric acid

Single dose

Trial Locations (1)

88397

Humanpharmakologisches Zentrum Biberach, Biberach

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT03414008 - This Study Tests How Different Doses of BI 1291583 Are Taken up in the Body and How Well They Are Tolerated | Biotech Hunter | Biotech Hunter